Buy pure BPC-157 (5mg and 10 mg) from polypeptide

BPC-157

BPC-157

Other names: BPC 157, BPC-157, Body Protection Compound 157, PL 14736, PL 10, PL 10-15, Bepecin, Pentadecapeptide BPC 157, Booly Protection Compound 15, Booly Protection Compound 157,PL 14736

BPC-157 is a pentadecapeptide comprising 15 amino acids. It is derived from the body protection compound (BPC) found and isolated from human gastric juice. Animal studies have demonstrated its ability to expedite the healing process for various types of injuries, including muscle, tendon, and ligament damage. Moreover, BPC 157 has exhibited organ-protective properties and has been found to aid in the prevention of gastric ulcers.

Production capacity: Provide customization

Large Factory Professional Manufacturers & Factory

Production Carried OUT Under CGMP Regulation and Trackable

ISO9001 & ISO14000

SHARE THIS

pinterest-logo 50x50 twitter logo Tumblr-LOGO 50x50 LinkedIn_logo_50x50LinkedIn_logo_50x50 LinkedIn_logo_50x50

Get a Bulk quotation

If you need a larger quantity. Please fill in the form, our BD (Business Development) will provide you with a competitive quotation.

BPC-157 Peptide dosage calculator

Referenced Citations

[1]Jelovac, Nikola; Sikiric, Predrag; Rucman, Rudolf; Petek, Marijan; Marovic, Anton; Perovic, Darko; Seiwerth, Sven; Mise, Stjepan; Turkovic, Branko; Dodig, Goran; Miklic, Pavle; Buljat, Gojko; Prkacin, Ingrid (1999). “Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats”. European Journal of Pharmacology. 379 (1): 19–31. doi:10.1016/S0014-2999(99)00486-0PMID 10499368.

[2] “PUBCHEM”. pubchem.ncbi.nlm.nih.gov. Retrieved 1 March 2021.

[3] “2022 Prohibited List: SUBSTANCES AND METHODS PROHIBITED AT ALL TIMES (IN- AND OUT-OF-COMPETITION)” (PDF). World Anti-Doping Agency. WADA. Retrieved 21 February 2022. 

[4] Sikiric, P.; Seiwerth, S.; Brcic, L.; Blagaic, A. B.; Zoricic, I.; Sever, M.; Klicek, R.; Radic, B.; Keller, N.; Sipos, K.; Jakir, A.; Udovicic, M.; Tonkic, A.; Kokic, N.; Turkovic, B.; Mise, S.; Anic, T. (2006). “Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response”. Inflammopharmacology. 14 (5–6): 214–21. doi:10.1007/s10787-006-1531-7PMID 17186181S2CID 24132425.

[5]Cerovecki, Tomislav; Bojanic, Ivan; Brcic, Luka; Radic, Bozo; Vukoja, Ivan; Seiwerth, Sven; Sikiric, Predrag (September 2010). “Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat”. Journal of Orthopaedic Research. 28 (9): 1155–1161. doi:10.1002/jor.21107ISSN 1554-527XPMID 20225319S2CID 22085833.

[6] Sikiric, P; Seiwerth, S; Rucman, R; Kolenc, D; Vuletic, LB; Drmic, D; Grgic, T; Strbe, S; Zukanovic, G; Crvenkovic, D; Madzarac, G; Rukavina, I; Sucic, M; Baric, M; Starcevic, N; Krstonijevic, Z; Bencic, ML; Filipcic, I; Rokotov, DS; Vlainic, J (2016). “Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications”. Current Neuropharmacology .14 (8): 857–865. doi:10.2174/1570159×13666160502153022PMC 5333585PMID 27138887.
[7]Gwyer D, Wragg NM, Wilson SLGastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.Cell Tissue Res.(2019-Aug).
[8]Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JHThe promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migrationJ Appl Physiol (1985).(2011 Mar).
[9]Cerovecki T, Bojanic I, Brcic L, Radic B, Vukoja I, Seiwerth S, Sikiric P. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthop Res. 2010 Sep;28(9):1155-61. doi: 10.1002/jor.21107. PMID: 20225319.
[10]Japjec M, Horvat Pavlov K, Petrovic A, Staresinic M, Sebecic B, Buljan M, Vranes H, Giljanovic A, Drmic D, Japjec M, Prtoric A, Lovric E, Batelja Vuletic L, Dobric I, Boban Blagaic A, Skrtic A, Seiwerth S, Predrag SStable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats.Biomedicines.(2021-Oct-27).
[11]Sven Seiwerth, Marija Milavic, Jaksa Vukojevic, Slaven Gojkovic, Ivan Krezic, Lovorka Batelja Vuletic, Katarina Horvat Pavlov, Andrea Petrovic, Suncana Sikiric, Hrvoje Vranes, Andreja Prtoric, Helena Zizek, Tajana Durasin, Ivan Dobric, Mario Staresinic, Sanja Strbe, Mario Knezevic, Marija Sola, Antonio Kokot, Marko Sever, Eva Lovric, Anita Skrtic, Alenka Boban Blagaic, Predrag SikiricStable Gastric Pentadecapeptide BPC 157 and Wound HealingFront Pharmacol.(2021 Jun 29).
[12]Huang BS, Huang SC”Pentadecapeptide BPC 157 efficiently reduces radiation-induced liver injury and lipid accumulation through Kruppel-like factor 4 upregulation both in vivo and in vitro”.Life Sci. 2022 Dec 1;310:121072. doi: 10.1016/j.lfs.2022.121072. Epub 2022 Oct 10.PMID: 36228773.
[13]Gamulin O, Oroz K, Coric L”Fourier Transform Infrared Spectroscopy Reveals Molecular Changes in Blood Vessels of Rats Treated with Pentadecapeptide BPC 157″Biomedicines. 2022 Dec 4;10(12):3130. doi: 10.3390/biomedicines10123130.PMID: 36551886.
[14]Zemba Cilic A, Zemba M”BPC 157, L-NAME, L-Arginine, NO-Relation, in the Suited Rat Ketamine Models Resembling “Negative-Like” Symptoms of Schizophrenia”.Biomedicines. 2022 Jun 21;10(7):1462. doi: 10.3390/biomedicines10071462.PMID: 35884767.
[15]Perovic D, Milavic M, Dokuzovic S”Novel Therapeutic Effects in Rat Spinal Cord Injuries: Recovery of the Definitive and Early Spinal Cord Injury by the Administration of Pentadecapeptide BPC 157 Therapy”.Curr Issues Mol Biol. 2022 Apr 27;44(5):1901-1927. doi: 10.3390/cimb44050130.PMID: 35678659.
[16]Jung YH, Kim H, Kim H, Kim E, Baik J, Kang H.”The anti-nociceptive effect of BPC-157 on the incisional pain model in rats.”J Dent Anesth Pain Med. 2022 Apr;22(2):97-105. doi: 10.17245/jdapm.2022.22.2.97. Epub 2022 Mar 25. PMID: 35449779

Author of this article:

Dr. Jean Zeng graduated from king’s college london Faculty of Life Sciences & Medicine.

Scientific Journal paper Author:

1.Ivan Barisic

Department of Pharmacology, University of Zagreb, Medical School, Salata 11, 10000 Zagreb, Croatia 

2.Sarah A. Deek

Department of Civil, Architectural and Environmental Engineering, The University of Texas at Austin, 78712 Austin, TX, USA.

3.Y. Tohyama

Department of Neurosurgery, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo, Hokkaido, 060-8638 Japan.

4.Robert Klicek

Department of Pharmacology, School of Medicine, University of Zagreb, Zagreb, Croatia

In no way does this doctor/scientist endorse or advocate the purchase, sale, or use of this product for any reason. Polypeptide.ltd has no affiliation or relationship, implied or otherwise, with this physician. The purpose of citing this doctor is to acknowledge, acknowledge and commend the exhaustive research and development work done by the scientists working on this peptide.

Author of this article:

Dr. Jean Zeng graduated from king's college london Faculty of Life Sciences & Medicine.

Scientific Journal paper Author:

Stephen C. Bain
Diabetes Research Group, Swansea University Medical School, Swansea, SA2 8PP, UK
Department of Diabetes and Endocrinology, Singleton Hospital, Swansea Bay University Health Board, Swansea, SA2 8QA, UK

In no way does this doctor/scientist endorse or advocate the purchase, sale, or use of this product for any reason. Polypeptide.ltd has no affiliation or relationship, implied or otherwise, with this physician. The purpose of citing this doctor is to acknowledge, acknowledge and commend the exhaustive research and development work done by the scientists working on this peptide.